Results 131 to 140 of about 7,072 (218)

Effect of Finerenone on the KCCQ in Patients With HFmrEF/HFpEF: A Prespecified Analysis of FINEARTS-HF.

Journal of the American College of Cardiology
Patients with heart failure (HF) are limited by symptoms and have impaired quality of life. The Kansas City Cardiomyopathy Questionnaire (KCCQ) is a patient-reported outcome measure that enables evaluation of the effect of HF and the impact of new therapies on health status in patients with HF.This prespecified analysis of FINEARTS-HF (Finerenone Trial
Yang M., Henderson A. D., Talebi A., Atherton J. J., Chiang C. -E., Chopra V., Comin-Colet J., Kosiborod M. N., Kerr Saraiva J. F., Claggett B. L., Desai A. S., Kolkhof P., Viswanathan P., Lage A., Lam C. S. P., Senni M., Shah S. J., Rohwedder K., Voors A. A., Zannad F., Pitt B., Vaduganathan M., Jhund P. S., Solomon S. D., McMurray J. J. V.   +24 more
openaire   +4 more sources

Heart Failure With Mildly Reduced Ejection Fraction: A Call for a Precision Medicine Approach. [PDF]

JACC Adv
Wu L, Rizwan A, Rodriguez M, El Hachem K, Hassan Virk HU, Khawaja M, Strauss M, Krittanawong C.   +7 more
europepmc   +1 more source

Development and Validation of a Prognostic Model to Predict Mortality in Patients With Heart Failure With Mildly Reduced Ejection Fraction After Acute Myocardial Infarction. [PDF]

Cardiol Res
Liu ZC, Zhang LL, Peng L, Zeng JP, Jiang MY.   +4 more
europepmc   +1 more source

Differential cardiovascular benefits of SGLT2 inhibitors, sacubitril/valsartan, omecamtiv mecarbil, and vericiguat across heart failure phenotypes: a systematic review and meta-analysis. [PDF]

Front Pharmacol
Wang M, Zuo Z, Wu T, Zhou Z.
europepmc   +1 more source

Prognostic Value of Cystatin C Across Ejection Fraction Spectrum in Heart Failure With Normal to Mild Renal Dysfunction Original Investigation. [PDF]

Clin Cardiol
Lyu L, Xu J, Yang Q, Wei Y, Hao B, Liu H.   +5 more
europepmc   +1 more source

Trends in Healthcare Costs in Heart Failure and Its Clinical Phenotypes During the Implementation of SGLT2 Inhibitors: A Finnish Registry Study. [PDF]

Clinicoecon Outcomes Res
Hansen JL, Tarkia M, Vasilevska M, Sandin P, Asllanaj E, Wammes K, Mesterton J, Airaksinen KEJ.   +7 more
europepmc   +1 more source

Angiotensin-converting enzyme inhibitors vs. receptor blockers in heart failure with mildly reduced ejection fraction. [PDF]

Front Cardiovasc Med
Weidner K, Behnes M, Reinhardt M, Abel N, Schmitt A, Lau F, Steffen HJ, Hetjens S, Duerschmied D, Akin I, Schupp T.   +10 more
europepmc   +1 more source

Prevalence of Tricuspid Regurgitation and Mortality Outcomes in Patients With Heart Failure: Stratification by Phenotype. [PDF]

JACC Adv
Mattig I, Romero Dorta E, Frumkin D, Kretzschmar H, Sommer A, Redel AM, Buchstaller J, Stangl K, Hindricks G, Dreger H.   +9 more
europepmc   +1 more source

Hoitosuositus uudistaa sydämen vajaatoiminnan kliinistä luokittelua [PDF]

, 2016
Lommi, Jyri
core  

Mechanisms and outcomes of heart failure: from HFpEF, HFmrEF, and HFrEF to transplantation [PDF]

European Heart Journal, 2018
openaire   +2 more sources